EcoDrugPlus

Inosine Monophosphate Dehydrogenase 2

Ensembl ID : ENSCPOG00000009955
Gene Symbol: IMPDH2
4 Cross references
202 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSCPOG00000011364
Gene Symbol: INPP5D
4 Cross references
214 Possible Orthologues:

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSCPOG00000005399
Gene Symbol: IGF1R
2 Cross references
276 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSCPOG00000012986
Gene Symbol: INSR
4 Cross references
290 Possible Orthologues:

Integrin Subunit Alpha 2b

Ensembl ID : ENSCPOG00000006801
Gene Symbol: ITGA2B
2 Cross references
191 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSCPOG00000009479
Gene Symbol: ITGA4
2 Cross references
237 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSCPOG00000007748
Gene Symbol: ITGA5
2 Cross references
267 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSCPOG00000015367
Gene Symbol: ITGAV
2 Cross references
243 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSCPOG00000009007
Gene Symbol: ITGB1
4 Cross references
301 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSCPOG00000011275
Gene Symbol: ITGB3
2 Cross references
268 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSCPOG00000009608
Gene Symbol: ITGB5
2 Cross references
212 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSCPOG00000012302
Gene Symbol: ITGB6
2 Cross references
205 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).